The Body Problem:
The AI Race Just Grew Legs
The token war was round one — open-weight Chinese models undercutting American frontier labs on price. Round two is physical. China shipped roughly nine of every ten humanoid robots sold on Earth last year, open-sourced the robot brains, and ordered 10,000 units into real jobs by New Year's Eve. The question is no longer whether AI escapes the data center. It's whose AI gets there first.
\nIn 2025, Chinese manufacturers — led by Unitree and AgiBot — shipped roughly 85–90% of the world's humanoid robots. American vendors shipped about 150 units apiece. Beijing has now mandated 10,000 humanoids into real work by December 31, its five-ministry action plan targets 100,000 deployed by 2027, and TrendForce expects global shipments to blow past 50,000 units this year — a 700% jump. Meanwhile the robot \"brains\" are going the way of Kimi and GLM: Chinese labs are open-sourcing embodied foundation models that now top real-world benchmarks over their best-funded American rival. The pattern from the token war is repeating in the physical world, and America's one clean shot at flipping the board — Optimus Gen 3 at automotive scale — hasn't left the factory yet.
\n01The Shipment Ledger
\nStrip away the kung-fu demos and the robot boxing leagues and look at the number that matters: units delivered for money. In 2025, global humanoid shipments landed somewhere between 13,000 and 18,000 depending on whose methodology you trust — Omdia, IDC, and Counterpoint all count differently — but every count agrees on the shape. Shanghai's AgiBot moved roughly 5,168 units. Hangzhou's Unitree disclosed more than 5,500 in its IPO prospectus. UBTECH and Leju filled in most of the rest. Chinese firms controlled somewhere near nine-tenths of everything that shipped.
\nThe American side of the ledger: Tesla, Figure AI, and Agility Robotics each delivered on the order of 150 units. Not fifteen thousand. One hundred fifty. BMW, Mercedes, and Hyundai are running pilots measured in single digits of robots per site. Boston Dynamics has begun commercial Atlas deployment, which is real progress — from a company that spent thirty years as the world's most impressive research lab that couldn't ship.
And 2025 was the warm-up. Unitree is targeting up to 20,000 humanoids in 2026 — its G1 production line went from 1,000 units to 5,000, then doubled to 10,000 within three months. Morgan Stanley raised its China shipment forecast from 28,000 to 50,000 units. TrendForce projects global shipments surging more than 700% year over year, with Chinese output alone growing 94% and Unitree plus AgiBot capturing nearly 80% of it. Unitree cleared its STAR Market IPO registration in 73 days flat — Beijing does not process paperwork that fast for companies it considers optional.
02The Mandate
\nIn June, China's government issued industry a direct instruction: by December 31, 2026, 10,000 humanoid robots must be actively working — in factories, warehouses, hospitals, and disaster-response operations. Not demoing. Not running marathons. Working. It sits under the 2025 Humanoid Robot Action Plan issued by MIIT and five other ministries, which targets 100,000 deployed humanoids by 2027, and above that, the 15th Five-Year Plan (2026–2030), which places robotics at the heart of China's \"modern industrial system\" and explicitly directs the country's AI research toward physical applications.
\nRead that last part again, because it's the strategic tell. While American capital debates whether frontier chatbots can grow revenue fast enough to justify a trillion dollars of data centers — the subject of Part One of this series — Beijing has formally decided that the payoff from AI is not tokens. It's labor. The plan treats language models as an input and robots as the product.
03The Price Collapse
\nHere is where the token-war déjà vu gets uncomfortable. The thing that made Kimi K3 and GLM-5.2 dangerous wasn't capability parity alone — it was capability parity at a tenth of the price. The same curve is forming in hardware. Unitree's entry R1 humanoid lists at $5,900. Its flagship G1 starts around $16,000, with the average selling price disclosed at 167,600 yuan — call it $23,000. Boston Dynamics' Atlas sits north of $250,000. Tesla is promising $20,000–$30,000 for Optimus at production scale, which would be genuinely competitive — when it exists at production scale.
The mechanism behind the price is the Yangtze River Delta supply chain. Unitree builds its own motors, reducers, and sensors in-house; its component suppliers sit within a two-hour logistics radius. A humanoid prototype that takes 12 weeks to fabricate in the US or Germany turns around in Shenzhen in 10–14 days at a fraction of the cost. That's not a subsidy story — it's the EV and drone industrial base being pointed at a new product category. The same actuator suppliers, the same battery chemistry, the same contract manufacturers, the same iteration cadence that let BYD and DJI eat their markets.
04The Brain Went Open-Weight Too
\nIf the hardware story rhymes with EVs, the software story rhymes with this series' opening act. On July 8, Ant Group's robotics arm open-sourced LingBot-VLA 2.0 under Apache 2.0 — a 6-billion-parameter vision-language-action model that runs the same trained policy across 20 distinct robot bodies from 17 brands without per-platform retraining, holds inference under 130 milliseconds, and beats Physical Intelligence's π0.5 across multiple hardware classes on the GM-100 bimanual manipulation benchmark. In January, startup Spirit AI's open-sourced Spirit v1.5 took the top slot on the RoboChallenge real-world benchmark — again over π0.5, the model from America's best-funded embodied-AI lab. AgiBot open-sourced its AgiBot World dataset. The pattern is identical to Kimi and GLM: give away the intelligence, commoditize your complement, monetize the thing you're structurally better at making — which in this case is the body.
\nChina's embodied-intelligence market was worth roughly 915 billion yuan in 2025 (~$135B) and is projected near 1.09 trillion yuan this year. The American answer — Physical Intelligence's π0.7, NVIDIA's GR00T family, Figure's Helix — is scientifically serious and, so far, mostly proprietary. Which means the American robot brain has the same problem as the American chatbot: it has to be worth paying for, forever, against a free alternative that improves every quarter.
05The Flywheel Is the Weapon
\nThe reason shipment volume matters more than demo quality is data. Embodied AI's structural bottleneck is that the physical world has no universal token — you can't scrape the internet for the feel of a warehouse tote. The only way to get manipulation data at scale is to have robots doing work, instrumented, in the field. LingBot-VLA 2.0 was trained on 60,000 hours of real robot data. Every one of the ten-thousand-plus Chinese humanoids fielded under the December mandate becomes a sensor package feeding the next model revision.
\nMorgan Stanley said it directly when it doubled its forecast: Chinese companies are leveraging large-scale deployments to generate the data needed to improve robot performance and accelerate commercialization. Deployment → data → capability → price cut → deployment. It's the flywheel in Figure 0, and the American strategy of perfecting the robot in the lab before shipping it is, functionally, a decision to let the other side spin it alone for another year.
06The Base Beneath the Base
\nHumanoids are the photogenic tip of a much larger iceberg. In conventional industrial robotics — the arms that actually build things — China installed 295,000 units in 2024, 54% of every industrial robot deployed on the planet, and its operational stock passed two million, about 4.5 times Japan's. The US installed 38,000 units in 2025, a healthy 11% rebound that the IFR rightly celebrated — and roughly one-tenth of China's run rate. For the first time, Chinese robot makers outsold foreign suppliers in their own home market, at 57% domestic share, up from about 28% a decade ago.
The honest wrinkle: on robot density — robots per 10,000 manufacturing workers — the IFR's 2025 revision actually dropped China to 166, well below the US at 307 and far below Korea's 1,220, after switching to what it considered more reliable Chinese employment data. Hawks should not skip that number, and doves should not over-read it: it reflects the sheer size of China's manufacturing workforce, not a lack of machines. A country installing ten times America's annual volume closes density gaps on a schedule, and A3's own president conceded China is \"likely to advance quickly.\" But it is a genuine data point against the ten-foot-tall version of this story.
07What America Actually Has
\nThe US position is not hopeless; it is concentrated. Frontier cognition still lives in American labs — nothing in the open-weight VLA world touches Fable-class reasoning, and the hard problems of long-horizon autonomy may ultimately be won by whoever owns the best general models. NVIDIA owns the training silicon both sides need. Atlas is genuinely in commercial deployment. Figure and Apptronik are demonstrating real autonomous work. And there is one asset that could rewrite the entire board: Optimus Gen 3, which Tesla intends to start producing at Fremont this summer, targeting $20,000–$30,000 — the only Western program even theoretically capable of automotive-scale volume. Tesla retired the Model S and X partly to fund it. If Gen 3 hits mass production on schedule, TrendForce notes it could restructure the global supply chain the way Tesla restructured EVs. That is a real scenario. It is also, as of this writing, a scenario about a factory line that hasn't started.
Absolute numbers are still tiny: 50,000 humanoids against a global labor force of 3.5 billion is a rounding error, and pilot-to-production attrition is brutal — many fielded units will underperform, and China's mandate-driven deployments risk Potemkin metrics (units \"working\" on paper to satisfy Beijing). Shipment counts conflict across Omdia, IDC, and Counterpoint by thousands of units. The IFR density revision cuts against the strongest version of the China thesis. Reliability, safety certification, and liability remain unsolved in every market. And the Optimus wildcard is live: one successful American mass-production line changes every chart in this article. Treat this as a trajectory read, not a settled outcome.
\n08Tripwires
\nAs with the data-center thesis in Part One, the way to hold this loosely is to watch for specific events rather than vibes:
\n- Optimus Gen 3 line rate. Sustained four-figure monthly output from Fremont is the single biggest possible update against this article's thesis.
- The December 31 audit. Whether China's 10,000-robot mandate produces verified working deployments or press-release deployments. Independent reporting from factory floors, not MIIT statements.
- Western enterprise POs. A Fortune 500 logistics or manufacturing firm signing a 500+ unit humanoid order — and whose robots they buy. Chinese hardware with an American brain would be its own signal.
- Open VLA benchmark flips. If π0.7 or GR00T retakes RoboChallenge/GM-100 leadership from open Chinese models — or if they don't by mid-2027.
- Export-control extension to actuators. Any US move to restrict harmonic reducers, high-torque motors, or rare-earth magnet supply chains signals Washington has recognized this as the next chip fight.
The through-line of this series has been that China's strategy is consistent across every theater: commoditize what America monetizes, then dominate the layer underneath. Tokens were the rehearsal. Bodies are the show. The intelligence was always going to escape the data center — the open question of 2026 is whether it walks out speaking English or Mandarin, and right now, only one side is manufacturing legs.
SOURCES: TrendForce · Omdia · IDC · Counterpoint Research · Morgan Stanley (via SCMP) · IFR World Robotics 2025 & Jun 2026 release · Unitree IPO prospectus disclosures · MIIT Humanoid Robot Action Plan · Ant Group / Robbyant LingBot-VLA 2.0 release · RoboChallenge leaderboard · eWeek · Forbes · TechTimes · SVRC — DATA AS OF JULY 2026.
ANALYSIS AND QUALITATIVE SCORING ARE THE AUTHOR'S. SHIPMENT FIGURES ARE ANALYST ESTIMATES AND VARY BY METHODOLOGY. NOT INVESTMENT ADVICE.\n